KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Depreciation and Depletion (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Depreciation and Depletion for 14 consecutive years, with $3.3 million as the latest value for Q1 2026.

  • For Q1 2026, Depreciation and Depletion rose 48.16% year-over-year to $3.3 million; the TTM value through Mar 2026 reached $11.1 million, up 19.21%, while the annual FY2025 figure was $10.0 million, 4.1% up from the prior year.
  • Depreciation and Depletion hit $3.3 million in Q1 2026 for Ionis Pharmaceuticals, up from $3.3 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $3.8 million in Q3 2022 and bottomed at $2.2 million in Q1 2025.
  • Average Depreciation and Depletion over 5 years is $2.8 million, with a median of $2.5 million recorded in 2024.
  • Year-over-year, Depreciation and Depletion crashed 33.9% in 2023 and then soared 48.16% in 2026.
  • Ionis Pharmaceuticals' Depreciation and Depletion stood at $3.0 million in 2022, then fell by 15.96% to $2.5 million in 2023, then decreased by 11.95% to $2.2 million in 2024, then skyrocketed by 45.49% to $3.3 million in 2025, then increased by 1.29% to $3.3 million in 2026.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $3.3 million, $3.3 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.